Reviews and Reflections David A

Total Page:16

File Type:pdf, Size:1020Kb

Reviews and Reflections David A Reviews and reflections David A. Bennahum, MD, and Jack Coulehan, MD, Book Review Editors There are a thousand ways that rective dose of potassium is the rem- things can go wrong when you’ve edy. And too much potassium can got a patient with a stab wound. But stop the heart, as well—that’s how everyone involved got almost every the states execute prisoners. step right—the head-to-toe exami- The senior anesthesiologist nation, the careful tracking of the asked to see the potassium bag that patient’s blood pressure and pulse had been hanging. Someone fished and rate of breathing, the monitor- it out of the trash and that was when ing of his consciousness, the fluids they figured it out. The anesthesiol- run in by IV, the call to the blood ogist had used the wrong concentra- bank to have blood ready, the place- tion of potassium, a concentration ment of a urinary catheter to make one hundred times higher than he’d sure his urine was running clear, intended. He had, in other words, everything. Except no one remem- given the patient a lethal dose of bered to ask the patient or the emer- potassium.p6 The Checklist Manifesto: How gency medical technicians what the To Get Things Right weapon was. Thepatientwasluckyandsurvived, “Your mind doesn’t think of a butGawandeusesthesestoriestoargue Atul Gawande bayonet in San Francisco,” John for a simple method to prevent such New York, Metropolitan Books, 2009 could only say.p3 errors, a checklist. In the first chapter Reviewed by David A. Bennahum, he writes about problems of extreme MD (AΩA, University of New Mexico, The staff knew that the patient had complexityandhowtrainingandprac- 1984) been stabbed, but he was comfortable tice can achieve astonishing results; and talking so no one thought to ask but he argues that in medicine we ex- withwhatandthenconsiderthepossi- pect miracles such as that offered by nThe Checklist Manifesto,hislatest bleconsequencesofadeepstabwound. penicillin. We have lost the discipline lucid and elegantly written analysis Inthesecondcase,apatientunder- that a methodical approach requires. Iof how to improve health care, Atul goingsurgerytoremoveacancerofthe More than 50 million operations are Gawande addresses the idea that the stomach suddenly went into cardiac performedannuallyintheUnitedStates simpleintroductionofcheckliststopa- arrest. Because the patient had a low and Americans undergo an average of tient care can reduce costs and save potassiumbeforesurgerytheanesthesi- seven operations in a lifetime. Yet we lives. In each of his books and essays ologisthadgivenhimcorrectivedoseof suffer150,000post-surgicaldeathseach Gawande has engaged the reader’s in- potassium.Gawandeinhisunderstated year.Gawandewrites: terestwithstoriesthatillustratespecific butdramaticstylequotesthesurgeon. points and problems. Here he begins Moreover, research has consistently with a surgical case that had been I was chagrined at having missed showed that at least half our deaths recounted to him by a physician this. An abnormal level of potas- and major complications are avoid- colleagueaboutapatientwho sium is a classic cause of asystole. able. The knowledge exists. But had almost exsanguinated It’s mentioned in every textbook. however supremely specialized and from an abdominal stab I couldn’t believe I overlooked it. trained we may have become, steps woundsodeepithad Severely low potassium levels can are still missed. Mistakes are still cuttheaorta. stop the heart, in which case a cor- made.p31 46 The Pharos/Winter2011 To better understand this idea Gawande finds that checklists “are Gawande turns to the introduction not comprehensive how-to guides, of checklists in 1935 by the U.S. Army whether for building a skyscraper or Aircorpswhenitwasflight-testingthe getting a plane out of trouble. They aircraft that would become the B17 are quick and simple tools aimed to bomber, the famous Flying Fortress. buttresstheskillsofexpertprofession- After a number of flight failures the als.”p128 He writes that on January 14, aeronauticalengineersrealizedthatthe 2009 the World Health Organization complexity of the modern airplane re- came out with a “Safe Surgery” check- quired not better test pilots but rather list.TheverynextdayCaptainChesley a simple method to prevent mistakes, B. Sullenberger III saved U.S. Airways thechecklist.Hefollowsthisbyremind- Flight1549afteraflockofCanadageese ingthereaderofthefourvitalsignsto flew into and stalled his aircraft’s en- which a fifth sign, pain, has recently gines. While the cool demeanor, good beenaddedandaskswhethertheseare judgment, and experience of the pilots notcheckliststhatguidenurses. andcrewwerecrucial,nolesssowere The Jump Artist Gawande recounts the remarkable theyearsofattentiontodetailandthe experience of Dr. Peter Pronovost at relentless discipline of their aviation Austin Ratner JohnsHopkinsin2001.Provonostiden- checklists. New York, Bellevue Literary Press, 2009 tified five steps that a physician must This is a marvelous and elegant Reviewed by Jeffrey L. Ponsky, take to place a central line and then book.Itisanimportantifverysimple— MD (AΩA, Case Western Reserve asked the nurses to observe whether butnotsimplistic—contributiontothe University, 1971) every physician unfailingly followed medical literature, as is almost every- each step. In more than a third of the thingthatGawandewrites.Whilemost patients, doctors skipped at least one. of the book focuses on the application nthetraditionofChekhov,Somerset Pronovost then persuaded the hospital ofcheckliststotechnicalpractice,there Maugham, and William Carlos administration to allow the nurses to isonepointthatIfoundveryappealing. IWilliamscomesanotherMDwhowrites stop any physician who had skipped a Gawande describes that as a surgeon beautiful and compelling literary fic- step. Over the next year “the ten-day introducing the checklist to his own tion.AustinRatner,agraduateofJohns line-infectionratewentfrom11percent surgical teams he now asks that they HopkinsMedicalSchool,turnedtofic- to zero.”p38 Only two line infections begin each operation by reintroducing tionasacareerafterreceivinghisMD. occurredoverthenextfifteenmonths! themselvestoeachother,therebylevel- His debut novel, The Jump Artist is a Pronovost had proven that checklists ingthedistinctionsbetweenphysicians, worthyadditiontotheranksofliterary raisedbaselineperformance. nurses, and technicians and creating historicalfiction. Gawandethengoesontoexplorethe a team of the moment for the ben- Thehistorythatformsthebasisfor use of checklists in several industries efitofthepatient.CaptainSullenberger thenovelisfascinatingandlargelyun- and the literature on complexity. He pointed out that he and his crew were known.PhilippeHalsmanwasayoung reports that researchers have defined also a team, each equally important to Latvian Jew hiking with his father in three categories of problems: simple, the final outcome. At the core of The the Tyrolean Alps when his father such as baking a cake; complicated, Checklist Manifestoisapleaforanethic fell to his death while walking behind such as sending a rocket to the moon; ofrelationshipbetweenindividualswho Philippe on the hiking path. In an af- andcomplex,suchasraisingachild.He worktogetheronanyprojectandespe- fair dubbed in Europe “The Austrian notestheevidenceinfavorofchecklists cially for those with a commitment to Dreyfuss Affair,” Philippe was arrested for simple and complicated problems, excellentpatientcare. and convicted of his father’s murder then asks whether checklists are also and imprisoned in an Austrian jail for helpful in situations of great complex- Dr.Bennahumisabookrevieweditorfor two years, despite only circumstantial ity. To address that question he cites The Pharosandamemberofitseditorial evidence. The young, still adolescent data from the building industry about board.Heisemeritus professorofInternal Halsman was thrown into a world of the construction of massive skyscrap- MedicineattheUniversityofNewMexico horror and only released by a pardon, ers.Andthereagainhefoundchecklists SchoolofMedicine.Hisaddressis: not an exoneration, after the tireless ateveryleveland“anannualavoidable 1707NotreDameDriveNE efforts of his sister Liouba and the as- failure rate of less than 0.00002 per- Albuquerque,NewMexico87106 sistance of human rights activists all cent.”p71 E-mail:[email protected] overtheworld,includingsuchnotables The Pharos/Winter2011 47 Reviews and reflections asAlbertEinstein,ThomasMann,and worldand,asthenovelbuilds,weroot family afloat financially and to further EleanorRoosevelt.Afterbeingreleased forhissuccess,hopinghewillovercome herfavoritechild’sambitiousgoals.This from prison, the young Halsman was thetragedyofhisyouth.Itisnotjustthe storyisinterwovenwiththehistoryof expelledfromAustriapermanentlyand storythatstayswithyou,itisHalsman the gradual recognition of Hodgkin’s went to Paris, to try fulfill his father’s thehumanbeing. disease as an entity, from Thomas dreamforhimofbecominganengineer As physicians we are always strug- Hodgkin’s original cases to Dorothy ordoctor.Aftermuchstruggle,Philippe gling to understand the human condi- Reed’s defining pathologic description, becameawell-knownParisianphotog- tion.Thisstunningnoveldoeswhatall aswellasthedevelopmentofradiation rapher,onlytofleeParisastheNazisin- truly fine novels should do. It illumi- therapy from a scientific curiosity to a vaded.Pennilessandstateless,Philippe nates an understanding of the human emigratedtotheUnitedStatesandrose condition through its moving explora- to become one of the country’s
Recommended publications
  • Sanofi-Aventis Press Release
    Sanofi-aventis press release Sanofi-aventis appoints Dr. Elias Zerhouni, President, Global Research & Development Paris, France - December 14, 2010 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) is pleased to announce the appointment of Dr. Elias Zerhouni as President, Global Research & Development, covering Medicines and Vaccines, effective January 1, 2011. Dr. Zerhouni will report directly to Christopher A. Viehbacher, Chief Executive Officer of sanofi-aventis, and join the Executive Committee and the Management Committee. Marc Cluzel, M.D., Ph.D., will resign as Executive Vice President, R&D but will continue to work closely with Elias as a scientific expert. “I would like to sincerely thank Marc for his long term contribution. His passion for science and commitment thus far has ensured a readiness to lead the implementation of the transformation of R&D over the past few years,” said Christopher A. Viehbacher, Chief Executive Officer of sanofi-aventis. Since his appointment as Scientific Advisor to Christopher Viehbacher in February 2009, Dr. Zerhouni has been instrumental in redesigning the R&D model to foster increased innovation, the first pillar of the Group’s strategy. The effect of this transformation has already delivered results with a reinvigorated R&D that will provide innovative solutions in response to specific, unmet needs of patients. Centered on the patient, the development of scientific networks and openness to the external scientific world has strengthened the creativity and the flexibility of the company and brought a truly entrepreneurial approach to research. “I have had the privilege of working with Elias for a long time. Through his vast experience and visionary approach, he has provided excellent advice and insight and has been central in implementing what is now one of the most promising R&D models in healthcare,” said Christopher A.
    [Show full text]
  • Eulogy for the Clinical Research Center
    Eulogy for the clinical research center David G. Nathan, David M. Nathan J Clin Invest. 2016;126(7):2388-2391. https://doi.org/10.1172/JCI88381. Op-Ed The extramural General Clinical Research Center (GCRC) program has been funded for more than 50 years, first by the National Center for Research Resources, NIH, and more recently as part of the Clinical Translational Science Award (CTSA) program through the newly formed National Center for Advancing Translation Sciences (NCATS). The GCRCs represent the federally funded laboratories that employ a highly trained cadre of research nurses, dietitians, and other support staff and in which generations of clinical investigators trained and performed groundbreaking human studies that advanced medical science and improved clinical care. Without the opportunity for adequate discussion, NCATS has now stopped funding these Research Centers. In this “eulogy,” we review the origins and history of the GCRCs, their contributions to the advancement of medicine, and the recent events that have essentially defunded them. We mourn their loss. Find the latest version: https://jci.me/88381/pdf OP-ED The Journal of Clinical Investigation Eulogy for the clinical research center David G. Nathan1 and David M. Nathan2 1Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. 2Diabetes Center and Clinical Research Center, Massachusetts General Hospital (MGH), Harvard Medical School, Boston, Massachusetts, USA. icans with a desire to learn the biomedical research technology of the early twentieth The extramural General Clinical Research Center (GCRC) program has been century were forced to travel to England, funded for more than 50 years, first by the National Center for Research France, Austria, or Germany.
    [Show full text]
  • Leading History Elias A. Zerhouni, MD December 19, 2019
    Episode 16: Leading History Elias A. Zerhouni, MD December 19, 2019 American College of Radiology, through its Radiology Leadership Institute (RLI), offers this podcast as one of a series of educational discussions with radiology leaders. The podcasts reflect the perspectives of the individual leaders, not of ACR or RLI. ACR disclaims liability for any acts or omissions that occur based on these discussions. Listeners may download the transcript for their own learning and share with their colleagues in their practices and departments. However, they may not copy and redistribute any portion of the podcast content for any commercial purpose. Episode 16: Leading History Elias A. Zerhouni, MD [00:00:01.282] Geoff: This month, we have an extra special holiday treat for you. As you will soon hear, Elias Zerhouni has had profoundly broad influence both within the field of radiology and well beyond it through the establishment of national policies for the organization and prioritization of health sciences research, advising international heads of state on science and technology strategy, facilitating the global availability of vaccines, and reorganizing one of the world's largest pharmaceutical companies to pivot from small molecule discovery to the development of therapeutic biologics. Elias Zerhouni has fearlessly approached his career as a series of professional disruptions that offer a lesson to us all in taking chances and making bold decisions. [00:00:51.453] No matter where you are in your career, as you listen to Elias's story, I invite you to reflect on your own journey and the decisions that you may be facing.
    [Show full text]
  • Interview with Dr. James Wyngaarden (JW) Jennifer Midura (JM), Center for Public Genomics, Institute for Genome Sciences & Policy, Duke University December 8, 2006
    Interview with Dr. James Wyngaarden (JW) Jennifer Midura (JM), Center for Public Genomics, Institute for Genome Sciences & Policy, Duke University December 8, 2006 JM: The information I am about to give you and your response will now be recorded. My name is Jennifer Midura and I am a student at Duke University. I am in a course on the history of genomics that includes oral history. One goal is to produce a written transcript of interviews with important figures in genomics. Some of the interviews may be archived or made public through a website. I selected you as the person I would like to interview. The interview should last about 45 minutes. Your participation in this interview is strictly voluntary, and you may withdraw at any time. You do not have to answer every question asked. The information that you provide will be “on the record” and may be attributed to you. This interview is being recorded and I will take written notes during the interview. The interviews that are posted publicly will be archived as a history resource. If you prefer that the interview be used only for the course and not made public, please indicate this. One risk of this study is that you may disclose information that later could be requested for legal proceedings. Or you may say something that embarrasses you or offends someone else when they read it on a public website. The benefit of participating in this study is ensuring that your side of the story is properly portrayed in the history of genomics.
    [Show full text]
  • Tyears the News Media Have Been Awash in Storie'abljut Increasingly Close Ties Between O College Campuses and Multimillion-Dollar Corpora­ - Tions
    :,1 C/) In recentyears the news media have been awash in storie'abljut increasingly close ties between o college campuses and multimillion-dollar corpora­ - tions. Our nation's universities, the story goes, reap m enormtus windfalls patenting products of scientific z ****************** ***~1* research that have been primarily funded by taxpay­ ers. Meanwhile, hoping for new streams of revenue SC IENCE SA{E from their innovations, the same universities are o j FOR allowing their research-and their very principles­ m to become compromised by quests for profit. But "Tl is that really the case? Is money really hopelessly o corrupting science? ;0 With Science for Sale, acclaimed journalist Daniel REliI\A~RmS, S. Greenberg reveals that campus capitalism is more ,THE PER I LS, complicated-and less profitable-than media reports C/) would suggest. While universities seek out corporate ",'AND DELUS IIQti;' '" \ funding, news stories rarely note that those industry » ~US ~ dollars are dwarfed by government support and r ·tfti/... ITA!..! s.M other funds. Also, while many universities have set up m technology-transfer offices to pursue profits through patents, many of those offices have been financial **;~:*.** busts. Meanwhile, science is showing signs of provid-: **'. ,. -: . :",,":);::,:!,:::,,:/..<':-:' ', **t*.' '::,:J<;," ****** ***.'*' * ing its own solutions, as highly publicized misdeeds in pursuit of profits have provoked promising counter­ measures within the field. But just because the threat is overhyped, Greenberg argues, doesn't mean that there's no danger. From research that's shifted overseas so corporations can avoid regulations to conflicts of interest in scientific I publishing, the temptations of money will always be I a threat, and they can only be countered through the viqilance of scientists, the press, and the public.
    [Show full text]
  • October 28, 2003, NIH Record, Vol. LV, No. 22
    R a StillThe SecondPayday BestThingAbout Hill Hearing Airs NIH Needs, Telework on the Rise Congress' Concerns By Rich McMenus Top Reasons More AreChoosing On the heels of the debut of NIH's new More NIH'ers Opt To Work Awayfrom Work To Work from Roadmap initiative and release of an Home Institute of Medicine report on the structure and vitality of NIH, a hearing was held Oct. t's not as if anyone needs added incentive to roll.out of bed a 2 at which director Dr. Elias Zerhouni ZerhouniLaunches little later, spend a few extra minutes with the family, steer reported to joint Senate and House Roadmap Initiative clear of rush-hour traffic or accomplish a day's work virtually uninterrupted.I No, the reason that committees on how closely the two visions merge as NIH faces its post-budget­ telework is growing-but still only doubling future. The directoralso heard a slowly-could be that few employees 'Director's Corner' realize the option may be available host of lawmakers' concerns, ranging from Speaks to NIH'ers A-76 to stem cells to studiesof human to them. However, as campus sexuality. parking spaces become rarer this fall, more people may be seeking-and NAS' Alberts To Zerhouni was joined at the witnesstable by more managers and supervisors Speak, Nov. 3 his predecessor, Dr. Harold Varmus, and by encouraging-ways to work away Dr. Harold Shapiro, who chaired the IOM from work. The trend is picking up committee on NIH revitalization; all three Cultural Lecture speed at NIH and throughout government.
    [Show full text]
  • Debt Ceiling Negotiations Come Down to the Wire
    PAGE 5 PAGE 6 INSERT Report: U.S. Lagging in Stem Cell Lawsuit The Role of the CDC in University R&D Dismissed Global Health R&D JULY-AUGUST 2011 ReTHEsearch ADVOCATE BRINGING RESEARCH CLOSER TO HOME Debt Ceiling Negotiations Come Down to the Wire At the time of this writing, debt ceiling tus to cut funding for health research these caps would limit the amount by negotiations between the White House and all discretionary programs has which agency budgets are able to grow. and congressional leadership have never been greater and it is up to you The National Institutes of Health stalled. Recent proposals for raising to turn the tide. budget, for example, is currently about the debt ceiling have included manda- If an agreement is reached, it could $31 billion for this fiscal year. A long- tory long-term spending cuts and result in deep cuts in funding for term spending cap would hamstring spending caps. Everyone in the health health research and long-term restric- funding for health research at NIH and research community needs to step up tions on any potential future increases other agencies. their advocacy efforts now. The impe- in discretionary spending. Ultimately, Continued on page 4 One Mind Forum Lays Out Plan the anniversary of tors and create partnerships toward the for Neuroscience Research former President goal of a greater understanding of brain John F. Kennedy’s disorders. The group hopes to raise an The One Mind for Research Forum, 1961 challenge to send a man to the additional $1.5 billion for brain held in Boston and featuring world- moon within a decade.
    [Show full text]
  • The Future of Genomic Medicine VI Conference
    Scripps Translational Science Institute In Partnership with AAAS/Science Translational Medicine Present The Future of Genomic Medicine VI Conference Scripps Seaside Forum ‐ Scripps Institution of Oceanography Robert Paine Scripps Forum for Science, Society and the Environment Samuel H. Scripps Auditorium La Jolla, California Thursday March 7th 2013 Friday March 8th 2013 Conference Faculty David Altschuler, MD, PhD Investigator of the Howard Hughes Medical Institute Professor of Genetics & Medicine, Harvard Medical School Professor of Genome Sciences Center for Human Genetic Research University of Washington Department of Molecular Biology Seattle, Washington Diabetes Unit, Department of Medicine Massachusetts General Hospital Jonathan Eisen, PhD Richard B. Simches Research Center Professor Director, Program in Medical and Population Genetics UC Davis Genome Center Broad Institute of Harvard and MIT Department of Evolution and Ecology, College of Biological Sciences Russ B. Altman, MD, PhD Department of Microbiology and Immunology, Associate Professor of Genetics and of Medicine School of Medicine Stanford University Davis, California Stanford, California David B. Goldstein, PhD Katrina Armstrong, MD, MSCE Director, Center for Human Genome Variation Professor of Medicine The Richard and Pat Johnson Distinguished University of Pennsylvania School of Medicine University Professor Philadelphia, Pennsylvania Duke Center for Human Genomic Variation Durham, North Carolina Mark T. Bertolini Chairman, Chief Executive Officer and President Jerome Groopman, MD Aetna Dina and Raphael Recanati Professor of Medicine, Harvard Medical School Cinnamon S. Bloss, PhD Chief of Experimental Medicine, Assistant Professor Beth Israel Deaconess Medical Center Scripps Translational Science Institute, Scripps Health & The Scripps Research Institute Susan Desmond Hellman, MD, MPh La Jolla, California Chancellor University of California, San Francisco Atul Butte, MD, PhD San Francisco, California Associate Professor, Pediatrics – Systems Medicine Stanford School of Medicine A.J.
    [Show full text]
  • Re-Engineering Clinical Research Hearing
    NIH: RE-ENGINEERING CLINICAL RESEARCH HEARING BEFORE THE SUBCOMMITTEE ON HEALTH OF THE COMMITTEE ON ENERGY AND COMMERCE HOUSE OF REPRESENTATIVES ONE HUNDRED EIGHTH CONGRESS SECOND SESSION MARCH 25, 2004 Serial No. 108–69 Printed for the use of the Committee on Energy and Commerce ( Available via the World Wide Web: http://www.access.gpo.gov/congress/house U.S. GOVERNMENT PRINTING OFFICE 93–301PDF WASHINGTON : 2004 For sale by the Superintendent of Documents, U.S. Government Printing Office Internet: bookstore.gpo.gov Phone: toll free (866) 512–1800; DC area (202) 512–1800 Fax: (202) 512–2250 Mail: Stop SSOP, Washington, DC 20402–0001 VerDate 11-MAY-2000 12:01 Apr 28, 2004 Jkt 000000 PO 00000 Frm 00001 Fmt 5011 Sfmt 5011 93301.TXT HCOM1 PsN: HCOM1 COMMITTEE ON ENERGY AND COMMERCE JOE BARTON, Texas, Chairman W.J. ‘‘BILLY’’ TAUZIN, Louisiana JOHN D. DINGELL, Michigan RALPH M. HALL, Texas Ranking Member MICHAEL BILIRAKIS, Florida HENRY A. WAXMAN, California FRED UPTON, Michigan EDWARD J. MARKEY, Massachusetts CLIFF STEARNS, Florida RICK BOUCHER, Virginia PAUL E. GILLMOR, Ohio EDOLPHUS TOWNS, New York JAMES C. GREENWOOD, Pennsylvania FRANK PALLONE, Jr., New Jersey CHRISTOPHER COX, California SHERROD BROWN, Ohio NATHAN DEAL, Georgia BART GORDON, Tennessee RICHARD BURR, North Carolina PETER DEUTSCH, Florida ED WHITFIELD, Kentucky BOBBY L. RUSH, Illinois CHARLIE NORWOOD, Georgia ANNA G. ESHOO, California BARBARA CUBIN, Wyoming BART STUPAK, Michigan JOHN SHIMKUS, Illinois ELIOT L. ENGEL, New York HEATHER WILSON, New Mexico ALBERT R. WYNN, Maryland JOHN B. SHADEGG, Arizona GENE GREEN, Texas CHARLES W. ‘‘CHIP’’ PICKERING, KAREN MCCARTHY, Missouri Mississippi, Vice Chairman TED STRICKLAND, Ohio VITO FOSSELLA, New York DIANA DEGETTE, Colorado STEVE BUYER, Indiana LOIS CAPPS, California GEORGE RADANOVICH, California MICHAEL F.
    [Show full text]
  • What People Are Saying About
    What People Are Saying about Key Quotes from Influencers Out of the Shadows dinner. the Trish and George team. Trish was dedicated e no for an Senator Roy Blunt (R-MO), Chairman, Subcommittee on the Departments of Labor, Health and Human Services, Education, and Related Agencies, Senate Committee on Appropriations Senator Patty Murray (D- Senator Susan Collins (R-ME), Co- they will be able to stop it in its Senator Amy Klobuchar (D- it should be bipartisan, it should be non-partisan, and it should be all of America, all hands on deck, all out to find the cure! Trish and George both they are insistent, they are persistent, and they are really a turbo team when it comes to Former Senator Barbara Mikulski (D-MD) national goal of 2025 if it weren't for George and Trish. We have greater resources devoted to preventing and treating the disease and an u Melody Barnes, former Director, White House Domestic Policy Council; Founding Member, many do in a life-long career. A lot of people have created organizations. George and Trish have created a nati Elias Zerhouni, MD, President, Global R&D, Sanofi; former Director, National Institutes of Health on many issues. Even among such leaders, George and Trish Vradenburg stand out for what they have from skeptical policymakers to exhausted caregivers to frustrated scientists n doing so, they have Diane Rehm, Host, On My Mind podcast; former Host/Executive Producer, The Diane Rehm Show (NPR); Member, WomenAgainstAlzh NO ONE is better positioned to make history than you, and I want to be right there when ve been easy and fair for George and Trish to rest on their laurels and enjoy a leisurely retirement.
    [Show full text]
  • October 6, 2006, NIH Record, Vol. LVIII, No. 20
    OCTOBER 6, 2006 The Second Best Thing About Payday VOL. LVIII, NO. 20 People Get Ready NIH Team Races to Prepare for Pandemic Flu By Belle Waring ABOVE · Pictures can be worth a thousand words in conveying health messages. See IH is developing a continuity of operations plan (COOP) for pandemic avian story below. N influenza (bird flu). The effort is being led by Dr. Pierre Noel, assisted by a team features of 10 working groups. The goal is to maintain critical operations and protect patients, visitors and employees, as well as animals and ongoing work. 1 “We need a critical number of employees to maintain operations [in the event Bird Flu Plan for Employees Takes Shape of an emergency],” Noel says. “A lot of people ask, ‘What if panflu does not occur?’ The answer is: We are working through a process that will apply to any emergency 3 on campus. Even if panflu never occurs, we will still be much better off because of ‘Energy Month’ Offers Ways to Save this effort.” 5 Chief of hematology in the Clinical Center’s department of laboratory medicine, Poster Day Honors NIA Retiree Noel was appointed last winter as pandemic flu COOP coordinator (seeNIH Record, Hughes Mar. 10, 2006). An Air Force Special Operations Command flight surgeon and an ad- 12 visor on weapons of mass destruction, disaster planning and biodefense, Noel also New ‘Captain’ Joins NIGMS recently accepted a detail as acting associate director for security and emergency see pandemic flu, page 8 departments Images Boost Health Extraordinary ‘Literacy’ Is the Norm for Bu Explores Use of Director’s Pioneers Briefs 2 Posters in Chinese Training 10 Public Health How can NIH help Milestones 11 By Belle Waring extraordinarily inno- vative scientists Say you have a pub- explore ideas that lic health problem have the potential whose scale is vast: for unusually high a population of 500 impact? One way million, with 90 per- is through the NIH cent living in the In 1965, a massive public Director’s Pioneer 2005 Pioneer Award countryside, where health campaign used posters Award program, part recipient Dr.
    [Show full text]
  • Elias Zerhouni, M.D. Professor Emeritus, Johns Hopkins University
    Elias Zerhouni, M.D. Professor Emeritus, Johns Hopkins University Elias Zerhouni, M.D., Professor Emeritus Radiology and Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA. Dr. Zerhouni was most recently the President, Global Research & Development, and a member of the Executive Committee for Sanofi from January 2011 to July 2018. Dr. Zerhouni’s academic career was spent at the Johns Hopkins University and Hospital where he was professor of Radiology and Biomedical engineering and senior adviser for Johns Hopkins Medicine. He served as Chair of the Russell H. Morgan Department of Radiology and Radiological Sciences, Vice Dean for Research and Executive Vice Dean of the School of Medicine from 1996 to 2002 before his appointment as Director of the National Institutes of Health from 2002 to 2008. In that position he oversaw the NIH’s 27 Institutes and Centers with more than 18,000 employees and a budget of $29.5 billion (2008). In November 2009, President Obama appointed Dr. Zerhouni as one of the first presidential U.S. science envoys. Dr. Zerhouni also served as senior fellow to the Bill and Melinda Gates foundation from 2009 to 2010 and senior advisor to the CEO of Sanofi. Dr. Zerhouni has founded or co-founded five start-up companies, authored more than 200 publications and holds several patents. He has assumed positions on several Boards, including most recently, the board of the Lasker Foundation, Research!America and the NIH Foundation. He is also a member of the U.S. National Academy of Medicine and the U.S. National Academy of Engineering.
    [Show full text]